You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API daunorubicin hydrochloride

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing daunorubicin hydrochloride

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Hikma Pharmaceuticals USA Inc	DAUNORUBICIN HYDROCHLORIDE	daunorubicin hydrochloride	0143-9551	SODIUM CHLORIDE
Hikma Pharmaceuticals USA Inc	DAUNORUBICIN HYDROCHLORIDE	daunorubicin hydrochloride	0143-9551	WATER
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing daunorubicin hydrochloride

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Teva Parenteral Medicines Inc	daunorubicin hydrochloride	0703-5233	HYDROCHLORIC ACID
Teva Parenteral Medicines Inc	daunorubicin hydrochloride	0703-5233	SODIUM CHLORIDE
Teva Parenteral Medicines Inc	daunorubicin hydrochloride	0703-5233	WATER
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for daunorubicin hydrochloride

Excipient focus: HYDROCHLORIC ACID

daunorubicin hydrochloride drug variants containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Teva Parenteral Medicines Inc	daunorubicin hydrochloride	0703-5233
Hisun Pharmaceuticals USA Inc	daunorubicin hydrochloride	42658-021
>Company	>Ingredient	>NDC

daunorubicin hydrochloride drug variants not containing HYDROCHLORIC ACID

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Hikma Pharmaceuticals USA Inc	daunorubicin hydrochloride	0143-9551
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

daunorubicin hydrochloride drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Hikma Pharmaceuticals USA Inc	daunorubicin hydrochloride	0143-9551
Teva Parenteral Medicines Inc	daunorubicin hydrochloride	0703-5233
Hisun Pharmaceuticals USA Inc	daunorubicin hydrochloride	42658-021
>Company	>Ingredient	>NDC

daunorubicin hydrochloride drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SODIUM HYDROXIDE

daunorubicin hydrochloride drug variants containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Hisun Pharmaceuticals USA Inc	daunorubicin hydrochloride	42658-021
>Company	>Ingredient	>NDC

daunorubicin hydrochloride drug variants not containing SODIUM HYDROXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Hikma Pharmaceuticals USA Inc	daunorubicin hydrochloride	0143-9551
Teva Parenteral Medicines Inc	daunorubicin hydrochloride	0703-5233
>Company	>Ingredient	>NDC

Excipient focus: WATER

daunorubicin hydrochloride drug variants containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Hikma Pharmaceuticals USA Inc	daunorubicin hydrochloride	0143-9551
Teva Parenteral Medicines Inc	daunorubicin hydrochloride	0703-5233
Hisun Pharmaceuticals USA Inc	daunorubicin hydrochloride	42658-021
>Company	>Ingredient	>NDC

daunorubicin hydrochloride drug variants not containing WATER

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.